Page last updated: 2024-10-23

aztreonam and Ischemia

aztreonam has been researched along with Ischemia in 1 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erturk, E1
Bretan, P1
Pestana, J1
Steinmuller, D1
Stowe, NT1
Novick, AC1

Other Studies

1 other study available for aztreonam and Ischemia

ArticleYear
The relative effects of aztreonam versus gentamicin on nephrotoxicity induced by warm ischemia in the presence and absence of cyclosporine.
    Transplantation proceedings, 1989, Volume: 21, Issue:1 Pt 1

    Topics: Animals; Aztreonam; Cyclosporins; Gentamicins; Ischemia; Kidney; Male; Rats; Rats, Inbred Strains; R

1989